This PDF is the current document as it appeared on Public Inspection on 06/20/2013 at 08:45 am.
In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC/Agency for Toxic Substances and Disease Registry (ATSDR), announces the following meeting and Tribal Consultation Session:
Name: Tribal Advisory Committee (TAC) Meeting and 10th Biannual Tribal Consultation Session.
Times and Dates:
8:00 a.m.-5:00 p.m., August 12, 2013 (TAC Meeting)
8:00 a.m.-5:00 p.m., August 13, 2013 (10th Biannual Tribal Consultation Session)
Place: The TAC Meeting and Tribal Consultation Session will be held at CDC Headquarters, 1600 Clifton Road, NE., Global Communications Center, Auditorium B2, Atlanta, Georgia 30333.
Status: The meetings are being hosted by CDC/ATSDR and are open to the public.
Purpose: In 2011-2012, CDC began revising its existing Tribal Consultation Policy (issued in 2005) with the primary purpose of providing guidance across the agency to work effectively with American Indian/Alaska Native (AI/AN) tribes, communities, and organizations to enhance AI/AN access to CDC resources and programs. Within the CDC Consultation Policy, it is stated that CDC will conduct government-to-government consultation with elected tribal officials or their authorized representatives before taking actions and/or making decisions that affect them. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding and comprehension. CDC believes that consultation is integral to a deliberative process that results in effective Start Printed Page 37542collaboration and informed decision making with the ultimate goal of reaching consensus on issues. Although formal responsibility for the agency's overall government-to-government consultation activities rests within the CDC Office of the Director (OD), other CDC Center, Institute, and Office (CIO) leadership shall actively participate in TAC meetings and HHS-sponsored regional and national tribal consultation sessions as frequently as possible.
Matters to Be Discussed: The TAC will convene their advisory committee meeting with discussions and presentations from various CDC senior leaders on activities and areas identified by TAC members and other tribal leaders as priority public health issues. The following topics are scheduled for presentation and discussion during the TAC Meeting; however, discussion is not limited to these topics: Native specimens, direct assistance and Epi-Aids, success stories, and disease specific topics.
The 10th Biannual Tribal Consultation Session will engage CDC senior leadership from the CDC OD and various CDC CIOs. Sessions that will be held during the Tribal Consultation include the following: A listening session with CDC's director, roundtable discussions with CDC senior leadership, and an opportunity for tribal testimony.
Additional opportunities will be provided during the Consultation Session for tribal testimony. Tribal Leaders are encouraged to submit written testimony by 12:00 a.m., EST on July 19, 2013, to Kimberly Cantrell, Deputy Associate Director for Tribal Support, OSTLTS, via mail to 4770 Buford Highway NE., MS E-70, Atlanta, Georgia 30341 or email to firstname.lastname@example.org. Depending on the time available, it may be necessary to limit the time of each presenter.
The agenda is subject to change as priorities dictate.
Information about the TAC, CDC's Tribal Consultation Policy, and previous meetings may be referenced on the following web link: http://www.cdc.gov/tribal.
Contact Person For More Information: April R. Taylor, Public Health Analyst, CDC/OSTLTS, via mail to 4770 Buford Highway NE., MS E-70, Atlanta, Georgia 30341 or email to ARTaylor@cdc.gov.
The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013-14779 Filed 6-20-13; 8:45 am]
BILLING CODE 4163-18-P